Advertisement

Topics

Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies / Water solubility significantly improved more than 100-fold, enabling novel pharmaceutical applications

09:01 EDT 19 Oct 2016 | FinanzNachrichten

LOS ANGELES, CA -- (Marketwired) -- 10/19/16 -- Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoi...

Original Article: Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies / Water solubility significantly improved more than 100-fold, enabling novel pharmaceutical applications

NEXT ARTICLE

More From BioPortfolio on "Vitality Biopharma Reports on Initial Cannabinoid Drug Formulation Studies / Water solubility significantly improved more than 100-fold, enabling novel pharmaceutical applications"

Quick Search
Advertisement